PHGE · Categories · Form 4

PHGE - SEC Form 4 insider transactions

BiomX Inc. (PHGE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PHGE

• 83d
  SEC Form 4 filed by Yeganeh Reuven

  4 - BiomX Inc. (0001739174) (Issuer)
• 88d
  Director Yeganeh Reuven sold $3,350,000 worth of shares (670,000 units at $5.00) and converted options into 670,000 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 412d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: SEC Form 4 filed by Director Merril Gregory Louis

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: Chief Development Officer Bassan Merav was granted 79,597 shares (SEC Form 4)

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: Chief Executive Officer Solomon Jonathan Eitan was granted 126,748 shares (SEC Form 4)

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: SEC Form 4 filed by Director Goodman Jesse

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: SEC Form 4 filed by Director Williams Eddie

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: SEC Form 4 filed by Director Moses Alan Charles

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: SEC Form 4 filed by Director Leff Jonathan S

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: SEC Form 4 filed by Director Blum Susan

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: SEC Form 4 filed by Director Greig Russell

  4/A - BiomX Inc. (0001739174) (Issuer)
• 414d
  Amendment: Chief Financial Officer Wolfson Marina was granted 68,545 shares (SEC Form 4)

  4/A - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  Chief Financial Officer Wolfson Marina was granted 68,545 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by Director Leff Jonathan S

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by Director Goodman Jesse

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by Director Greig Russell

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  Chief Development Officer Bassan Merav was granted 79,597 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by Director Merril Gregory Louis

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  Chief Executive Officer Solomon Jonathan Eitan was granted 126,748 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by Director Moses Alan Charles

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by Director Blum Susan

  4 - BiomX Inc. (0001739174) (Issuer)
• 417d
  SEC Form 4 filed by Director Williams Eddie

  4 - BiomX Inc. (0001739174) (Issuer)
• 462d
  SEC Form 4 filed by Large owner Cystic Fibrosis Foundation

  4 - BiomX Inc. (0001739174) (Issuer)
• 463d
  *Director by Deputization Flynn James E exercised 706,498 shares at a strike of $0.93 (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 629d
  Chief Business Officer Oron Assaf was granted 25,804 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 629d
  Chief Executive Officer Solomon Jonathan Eitan was granted 50,556 shares, increasing direct ownership by 2,022% to 53,056 units (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 629d
  Chief Development Officer Bassan Merav was granted 31,749 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 692d
  *Director by Deputization Flynn James E converted options into 11,766,000 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Director Blum Susan

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Director Greig Russell

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Chief Development Officer Bassan Merav

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Chief Financial Officer Wolfson Marina

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Chief Executive Officer Solomon Jonathan Eitan

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Director Leff Jonathan S

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Director Goodman Jesse

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Director Merril Gregory Louis

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Director Williams Eddie

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Chief Business Officer Oron Assaf

  4 - BiomX Inc. (0001739174) (Issuer)
• 694d
  SEC Form 4 filed by Director Moses Alan Charles

  4 - BiomX Inc. (0001739174) (Issuer)
• 698d
  SEC Form 4 filed by *Director by Deputization Flynn James E

  4 - BiomX Inc. (0001739174) (Issuer)
• 750d
  Orbimed Israel Biofund Gp Limited Partnership exercised 9,280,408 in-the-money shares at a strike of $0.24 and sold $9,280 worth of shares (24,344 units at $0.38) (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 753d
  Cystic Fibrosis Foundation exercised 4,778,265 in-the-money shares at a strike of $0.00, increasing direct ownership by 105% to 9,330,580 units (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 812d
  Flynn James E was granted 6,110,098 shares (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 812d
  SEC Form 4 filed by Orbimed Israel Biofund Gp Limited Partnership

  4 - BiomX Inc. (0001739174) (Issuer)
• 909d
  SEC Form 4 filed by Wolfson Marina

  4 - BiomX Inc. (0001739174) (Issuer)
• 909d
  SEC Form 4 filed by Bassan Merav

  4 - BiomX Inc. (0001739174) (Issuer)
• 909d
  SEC Form 4 filed by Solomon Jonathan Eitan

  4 - BiomX Inc. (0001739174) (Issuer)
• 909d
  SEC Form 4 filed by Oron Assaf

  4 - BiomX Inc. (0001739174) (Issuer)
• 921d
  Oron Assaf sold $4,072 worth of shares (10,914 units at $0.37), closing all direct ownership in the company (SEC Form 4)

  4 - BiomX Inc. (0001739174) (Issuer)
• 952d
  SEC Form 4 filed by Bassan Merav

  4 - BiomX Inc. (0001739174) (Issuer)
• 952d
  SEC Form 4 filed by Wolfson Marina

  4 - BiomX Inc. (0001739174) (Issuer)
• 952d
  SEC Form 4 filed by Solomon Jonathan Eitan

  4 - BiomX Inc. (0001739174) (Issuer)
• 952d
  SEC Form 4 filed by Oron Assaf

  4 - BiomX Inc. (0001739174) (Issuer)
• 960d
  SEC Form 4 filed by Williams Eddie

  4 - BiomX Inc. (0001739174) (Issuer)
• 1021d
  SEC Form 4 filed by Marks Jason M.

  4 - BiomX Inc. (0001739174) (Issuer)
• 1021d
  SEC Form 4 filed by Dambach Michael E.

  4 - BiomX Inc. (0001739174) (Issuer)
• 1112d
  SEC Form 4 filed by Oron Assaf

  4 - BiomX Inc. (0001739174) (Issuer)

Other PHGE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends